Sabine Haubenreisser holds a Master in Pharmaceutical Science from the Johann Wolfgang Goethe-Universität in Frankfurt am Main, a Ph.D. in Pharmacology from the Pharmakologisches Institut für Naturwissenschaftler in Frankfurt am Main, and a certificate in Epidemiology from the London School of Hygiene and Tropical Medicine.
She joined the European Medicines Agency (EMA) in 1997, where she held positions as support to the Head of Human Unit, as Project Manager in the Sector of New Chemical Substances, as Secretary to the Mutual Recognition Facilitation Group and from 2001 to 2009 as Specialised Group Leader of the Team Anti-Infectives, Immunology, Gastroenterology and Musculoskeletal in the Post-Authorisation Human Unit.
From 2009 to 2012 she worked as Officer for External Communications and Media in the Office of the Executive Director, where she developed communication strategies and prepared EMA public communications.
In May 2012 she was appointed as EMA Liaison Official at the U.S. FDA and is based at the campus in White Oak, Silver Spring, MD, United States. In this role she facilitates cooperation between the European Regulatory Network for medicines and the Food and Drug Administration, promoting shared regulatory and scientific understanding and convergence of both regions.